TP53 and dilated cardiomyopathy: Of note, mutant LMNAD300N predisposing to dilated cardiomyopathy in humans was shown to induce an aberrant DNA damage response involving ATM and p53, which could be partly rescued by p53 deletion in transgenic mice [65].